Our story of
transformation

EDITGENE developed CRISPR-EDITx™ platform and Bingo™ prime editing point mutation platform and provided hundreds of CRO services (gene knockout, overexpression, endogenous point mutation and CRISPR library screening, etc.) to various research institutes and enterprises. Promote the application of CRISPR/Cas technology.

In terms of molecular diagnosis, our technical team developed a better Cas12 and Cas13 protein purification platform, and discover ed the optimal crRNA design principle . Thus, we established FASST detection technology, which greatly improved the sensitivity of CRISPR detection.

In addition to providing gene editing services, EDITGENE develops the industrial application of CRISPR in disease diagnosis and treatment, promotes the application of gene editing technology through services, and at the same time carries out the industrial application of CRISPR in disease diagnosis and treatment, forming a closed-loop model of R&D-service-industry, promoting the development of gene editing application in life science and human health.